
A phase I study of the effects of intravenous administration of zzso on 31 patients was zzso The effects of dose, schedule, and chronic administration were zzso In the first phase of the study, a dose range of zzso zzso zzso zzso was tested and we found the maximum tolerated dose to be 400 zzso the zzso toxicity with this preparation was zzso In the second phase, three different schedules of administration were zzso There were no significant differences in toxicity between a 20 zzso a 4 zzso or a 24 h infusion of 60 zzso (3 zzso In the third phase, patients received chronic administration of either 1 or 30 zzso Patients given 30 zzso twice a week for 4 weeks showed more zzso zzso and zzso those treated with 1 zzso No significant changes were seen in natural killer cell activity, zzso complement zzso or zzso zzso at any zzso zzso stimulation of zzso zzso occurred at low doses (12 zzso zzso bone zzso colony formation for zzso zzso and zzso in zzso was zzso No objective zzso responses were zzso This preparation of zzso zzso can be given in doses as high as 400 zzso zzso administration would appear to be limited to 30 zzso However, lower doses may give zzso zzso zzso These studies provide further information on the zzso effects of a wide dose range and a variety of schedules of zzso zzso 

